《新股消息》心瑋醫療科技(06609.HK)公開發售超購332倍及上限定價 一手中籤率10%
心瑋醫療科技(06609.HK)公布招股結果,發售價已釐定為171元,為上限定價(招股價介乎160元至171元),公開發售錄超購332.14倍,經重新分配後,香港公開發售股數增至50%。每手50股,中籤率為10%。該股將於明日(8月20日)上市。高盛及中金為聯席保薦人。
該公司引入10名基石投資者,包括清池資本、博裕資本等,合共認購約300萬股股份,佔緊隨全球發售完成後公司已發行股本約7.73%。
公司預計集資所得款項淨額為10.15億元,當中約45.3%預期將分配至核心產品;約39.9%分配至管線內的其他在研產品;約4.8%用於為透過內部研究提升研發能力及持續擴充產品組合提供資金;10%作營運資金及一般企業用途。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.